Assessing Nuvation Bio (NUVB) Valuation After Bullish Analyst Calls On Ibtrozi And mIDH1 Glioma Potential [Yahoo! Finance]
Nuvation Bio Inc. Class A (NUVB)
Company Research
Source: Yahoo! Finance
Recent research updates on Nuvation Bio (NUVB) have drawn investor attention, as multiple firms highlighted stronger than expected early demand for the Ibtrozi franchise and future potential tied to the company's mIDH1 glioma program. See our latest analysis for Nuvation Bio. Even with recent enthusiasm around Ibtrozi and the mIDH1 glioma program, Nuvation Bio's share price has been volatile. The 30 day share price return is around a 39% decline, but there is also a very large 1 year total shareholder return. This suggests that earlier optimism has cooled in the short term while longer term holders are still well ahead. If this kind of volatility has your attention, it could be a good moment to scan other oncology names and see how they compare using healthcare stocks With Nuvation Bio's share price sliding 39% over 30 days, but still delivering a very large 1-year total return and trading below analyst targets, is there still upside available, or is the market already pricin
Show less
Read more
Impact Snapshot
Event Time:
NUVB
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
NUVB alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
NUVB alerts
High impacting Nuvation Bio Inc. Class A news events
Weekly update
A roundup of the hottest topics
NUVB
News
- Nuvation Bio: Rollout Data Of Ibtrozi Support A Modest Buy [Seeking Alpha]Seeking Alpha
- Truist Highlights Nuvation Bio's (NUVB) Ibtrozi's Robust Market Uptake and Lead Over Competitors [Yahoo! Finance]Yahoo! Finance
- Nuvation Bio (NYSE:NUVB) was given a new $13.00 price target on by analysts at Truist Financial Corporation.MarketBeat
- Nuvation Bio (NYSE:NUVB) had its "outperform" rating reaffirmed by analysts at Royal Bank Of Canada.MarketBeat
- Here's What the Wall Street Thinks About Nuvation Bio Inc. (NUVB) [Yahoo! Finance]Yahoo! Finance
NUVB
Earnings
- 11/3/25 - Beat
NUVB
Sec Filings
- 1/12/26 - Form 8-K
- 12/3/25 - Form 4
- 12/1/25 - Form 144
- NUVB's page on the SEC website